ResearcherUniversity of Chemistry and Technology, PragueNo recent work listed

Lenka Michálková

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8119-004X; OpenAlex author ID A5041859901. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

Early Detection of Pancreatic Cancer in Type 2 Diabetes Mellitus Patients Based on 1H NMR Metabolomics. Co-author DOI 10.1021/acs.jproteome.0c00990 ↗
Diagnosis of pancreatic cancer via1H NMR metabolomics of human plasma. Co-author DOI 10.1039/c8an01310a ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lucie Habartová · 2 shared papers, 2018–2021 · strength 0.26
- Paper Early Detection of Pancreatic Cancer in Type 2 Diabetes Mellitus Patients Based on 1H NMR Metabolomics. DOI 10.1021/acs.jproteome.0c00990 ↗
- Paper Diagnosis of pancreatic cancer via1H NMR metabolomics of human plasma. DOI 10.1039/c8an01310a ↗
Vladimı́r Setnička · 2 shared papers, 2018–2021 · strength 0.26
- Paper Early Detection of Pancreatic Cancer in Type 2 Diabetes Mellitus Patients Based on 1H NMR Metabolomics. DOI 10.1021/acs.jproteome.0c00990 ↗
- Paper Diagnosis of pancreatic cancer via1H NMR metabolomics of human plasma. DOI 10.1039/c8an01310a ↗
Bohuš Bunganič · 1 shared paper, 2021 · strength 0.16
- Paper Early Detection of Pancreatic Cancer in Type 2 Diabetes Mellitus Patients Based on 1H NMR Metabolomics. DOI 10.1021/acs.jproteome.0c00990 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.